Abstract:
The present invention discloses an aminothiol compound having a general formula I wherein R 1 -R 5  are substitutable ligands. Such compound can perform as a superior catalyst in an asymmetric addition reaction of organic metal compounds and aldehyde. According to the present invention, the aminothiol compound is needed only less than 0.02% based on main reactants to obtain enantioselectivity higher than 98% enantiomeric excess, whereby the asymmetric reactions can become very economic.

Description:
CROSS-REFERNCE TO RELATED APPLICATION  
       [0001]    This is a CIP application of U.S. patent application Ser. No. 10/039,557 filed on Jan. 8, 2002, and for which priority is claimed under 35 U.S.C.sctn.120.  
     
    
     
       BACKGROUND OF THE INVENTION  
         [0002]    1. Field of the Invention  
           [0003]    The present invention relates aminothiol compounds which perform as superior catalysts in the asymmetric addition reactions of organic zinc and aldehyde.  
           [0004]    2. Description of the Related Technology  
           [0005]    For preparing secondary alcohols, one of the most important methods is to react organic zinc with aldehyde in addition reactions. In order to accelerate this reaction, chiral aminoalcohols are usually added as ligands to combine with organic zinc. Such chiral aminoalcohol create an asymmetric reaction environment, so that one of the produced chiral secondary alcohols is produced more than its stereoisomer, i.e., the asymmetric addition reactions. Apparently, the crux of obtaining a high chemical yield as well as enantioselectivity in the above reactions is to select proper chiral compounds which can provide excellent asymmetric environment for catalytical process.  
           [0006]    Though many chiral compounds used in the addition reactions regarding organic zinc and aldehyde can achieve good enantioselectivity, however, these compounds have to be added at an amount at least 1% of the main reactants, and usually around 20%. Additionally, the enantioselectivity always decays with decreasing amount of the chiral ligands used. In general, the enantioselectivity is reduced below 90% enantiomeric excess (e.e.) when the chiral ligands are descended under 5%, so that most of above reactions are not good enough for industrial usage.  
           [0007]    Aminoalcohols with optical activity, such as N,N-dibutylnorephe-edine, are frequently applied to accelerating the asymmetric addition reactions of organic zinc and aldehyde as chiral ligand catalysts. By adding aminoalcohols, enantioselectivity of the above reactions can be reached as high as 99% e.e., but an amount 10-20% of chiral aminoalcohols is need. Therefore, it&#39;s an important issue how to reduce the necessary amount of the chiral ligands used in the catalysis, so that it can be an economically efficient process  
         SUMMARY OF THE INVENTION  
         [0008]    The object of the present invention is to provide aminothiol compounds with two chiral centers, which can increase enantioselectivity of asymmetric addition of organic zinc and aldehyde.  
           [0009]    In order to achieve the above object, the present invention discloses an aminothiol compound having a general formula I;  
                         
 
           [0010]    wherein R 1 -R 5  are substitutable ligands.  
           [0011]    According to the present invention, the aminothiol compounds can perform as superior catalysts in asymmetric addition reactions wherein organic zinc and aldehyde are involved. In such reactions, though the catalysts are added only 0.1% or even 0.02%, enantioselectivity higher than 98% e.e. can always be obtained. Such catalyses are economically useful for industries. 
       
    
    
     DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS  
       [0012]    In the present invention, aminothiol compounds have a general formula I,  
                         
 
         [0013]    wherein R 1  is aryl or alkyl of C1-C9;  
         [0014]    R 2  is aryl or alkyl of C1-C9;  
         [0015]    R 3  is aryl or alkyl of C1-C9;  
         [0016]    R 4  is aryl or alkyl of C1-C9; or  
         [0017]    R 3 , R 4  and N can form a three-to-eight-membered heterocycle; and  
         [0018]    R 5  can be H or alkyl of C1-C6.  
         [0019]    [Preparation Mode] 
         [0020]    In general, the aminothiol compounds can be prepared through procedures shown in Scheme A.  
                         
 
         [0021]    Scheme A includes steps of: (a) reacting amino-alcohol with bromo-compound and carbonate of alkaline metal to form the specific ligand of R 3 , R 4  and N; (b) replacing —OH with —SAc by adding MeSO 2 Cl and NEt 3  (c) adding LiAlH 4  to form —SH.  
         [0022]    The following EXAMPLEs indicate procedures for preparing representative aminothiol compounds of the present invention. Table 1 lists codes of different ligands shown in the compound of formula (I), so that the aminothiol compounds of the present invention can be simply represented with combinations of such codes.  
                                                             TABLE 1                           R 1     R 2     N-R 3 -R 4     R 5              code   ligand   code   ligand   code   ligand   code   ligand               2   methyl   b   methyl   2   Bu n     c   H                           (n-butyl)       3   Bu n     c   Bu n     3   Bn           (n-butyl)       (n-butyl)       (benzyl)       4   i-butyl   f   i-propyl   4   pyrro-                           lidinyl       5   Bn   g   Ph   5   piperidyl           (benzyl)       (phenyl)       6   i-propyl           6   morpho-                           linyl       7   Ph           (phenyl)                  
 
         [0023]    For example, compound (2b4c) is an aminothiol compound of the present invention, wherein R 1  is methyl; R 2  is methyl; N, R 3  and R 4  form a membered membered heteorocycle, pyrrolidinyl; and R 5  is H. As for the middle product obtained in step (a), the last code “a” represents the alcohol ligand, —OH.  
       EXAMPLES 1 and 2  
     Preparation of (2R,3S)-4-Methyl-3-(1-pyrrolidinyl) Pentane-2-thiol (6b4c) and (3R,4S)-2-Methyl-4-(1-pyrrolidinyl) pentane-3-thiol (2f4c)  
       [0024]    Step (a): Preparing (2R,3S)-4-Methyl-3-(1-pyrrolidinyl) pentan-2-ol (6b4a)  
                         
 
         [0025]    To a three-necked flask, (2R,3S)-3-amino-4-methylpentan-2-ol (0.585g, 5.0 mmol), Na 2 CO 3  (1.16g, 11.0 mmol) and CH 3 CN (20 mL) are added under the nitrogen system and then heated with refluxing. Next, Br 2 C 4 H 8  (1.295g, 6.0 mmol) is injected into the solution. After complete reaction for 12 hours, H 2 O (20 mL) is added to terminate the reaction. The product is repeatedly extracted with EtOAc (20 mL), wherein the organic phase is dehydrated with Na 2 SO 4 . A coarse product is obtained after filtration and concentration. Column chromatography (Silica gel 50 g, eluent is n-Hexane:EtOAc=1:1) is used to purify the coarse product and a slightly-yellow liquid (0.85 g) is obtained. The yield is 85% and the other analysis includes:  
         [0026]    [0026] 1 H NMR (400 MHz, CDCl 3 ) δ 0.87 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 0.96 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 1.05 (d, J=6.4 Hz, 3H, CHOHCH 3 ), 1.72-1.79 (m, 4H, —(CH 2 ) 2 —), 1.82-2.00 (m, 1H, CH(CH 3 ) 2 ), 2.48 (dd, J 1 =4.8 Hz, J 2 =10.0 Hz, 1H, NCH), 2.80-2.92 (m, 4H, NCH 2 —), 3.70-3.80 (m, 1H, CHOH)  
         [0027]    [0027] 13 C NMR (100 MHz, CDCl 3 ) δ 18.59 (CHOHCH 3 ), 19.80 (CH(CH 3 ) 2 ), 21.38 (CH(CH 3 ) 2 ), 23.93 (—CH 2 —) 27.30 (CH(CH 3 ) 2 ), 50.91 (NCH 2 —), 65.64 (NCH), 69.50 (CHOH)  
         [0028]    Element analysis: C 10 H 21 NO theoretical: C, 70.12; H, 12.36; N, 8.18 experimental: C, 71.16; H, 12.28; N, 8.14  
         [0029]    High-resolution MS (70 eV) m/e theoretical: 171.1623 experimental: 172.1699  
         [0030]    [α] 25   D =+42.1 (c=1.45, CDCl 3 )  
         [0031]    Step (b): Preparing (2R,3S)-4-Methyl-3-(1-pyrrolidinyl)-2-thioacetylpentane (6b4b)  
                         
 
         [0032]    and (3R,4S)-2-Methyl-4-(1-pyrrolidinyl)-3-thioacetylpentane (2f4b)  
                         
 
         [0033]    To a three-necked flask, compound (6b4a) (0.855g, 5.0 mmol), CH 2 Cl 2  (20 mL) and NEt 3  (1.01 g, 10.0 mmol) are added under nitrogen system. Next, MeSO 2 Cl (0.69 g, 6.0 mmol, dissolved in 20 mL CH 2 Cl 2 ) is added dropwisely at 0° C. After complete reaction for 2 hours, a coarse product is obtained through repeated depressing concentration and adding benzene therein. The coarse product is then added into benzene (20 mL) with refluxing, and MeCOSH (0.46 g, 6.0 mmol) and NEt 3  (1.01 g, 10.0 mmol) dissolved in 20 mL benzene are injected into the above solution under the nitrogen system. After 12 hours, H 2 O (20 mL) is added to terminate the reaction. The product is repeatedly extracted with EtOAc (20 mL), wherein the organic phase is dehydrated with Na 2 SO 4 . A coarse product is obtained after filtration and concentration. Column chromatography (Silica gel 70 g, eluent is n-Hexane:NEt 3 =100:1) is used to purify the coarse product and two orange liquids, compound (6b4b) (0.229 g) and compound (2f4b) (0.458 g), are obtained. The yields of compound (6b4b) and compound (2f4b) are 20% and 40%, respectively. The other analysis for compound (6b4b) includes:  
         [0034]    [0034] 1 H NMR (400 MHz, CDCl 3 ) δ 0.92 (d, J=7.2 Hz, 3H, CH(CH 3 ) 2 ), 0.94 (d, J=7.2 Hz, 3H, CH(CH 3 ) 2 ), 1.27 (d, J=6.8 Hz, 3H, SCHCH 3 ), 1.66-1.73 (m, 4H, —(CH 2 ) 2 —), 1.90-2.05 (m, 1H, CH(CH 3 ) 2 ), 2.27 (s, 3H, SCOCH 3 ), 2.41 (dd, J 1 =3.2 Hz, J 2 =8.0 Hz, 1H, NCH), 2.67-2.74 (m, 2H, NCH 2 —), 2.75-2.81 (m, 2H, NCH 2 —), 3.86-4.05 (m, 1H, SCH)  
         [0035]    [0035] 13 C NMR (100 MHz, CDCl 3 ) δ 18.38 (SCHCH 3 ) 20.37 (CH(CH 3 ) 2 ), 21.18 (CH(CH 3 ) 2 ), 24.20 (—CH 2 —), 29.40 (CH(CH 3 ) 2 ), 30.66 (SCOCH 3 ), 43.29 (NCH) 51.06 (NCH 2 —), 69.61 (SCHCH 3 ), 196.77 (SCOCH 3 )  
         [0036]    Element analysis C 12 H 23 NOS theoretical: C, 62.83; H, 10.11; N, 6.11 experimental: C, 62.90; H, 10.10; N, 6.02  
         [0037]    High-resolution MS (70 eV) m/e theoretical: 229.1500 experimental: 229.1523  
         [0038]    [α]25D=+48.1 (c=1 0.05, CDCl 3 )  
         [0039]    The other analysis for compound (2f4b) includes:  
         [0040]    [0040] 1 H NMR (400 MHz, CDCl 3 ) δ 0.91 (d, J=6.8 Hz, 3H, CH(CH 3 ) 2 ), 0.96 (d, J=7.2 Hz, 3H, CH(CH 3 ) 2 ), 1.03 (d, J=6.8 Hz, 3H, NCHCH 3 ), 1.68-1.73 (m, 4H, —(CH 2 ) 2 —), 1.86-2.11 (m, 1H, CH(CH 3 ) 2 ), 2.33 (s, 3H, SCOCH 3 ), 2.42-2.64 (m, 4H, NCH 2 —), 2.42-2.64 (m, 1H, NCH), 3.60 (dd, J 1 =4.8 Hz, J 2 =8.0 Hz, 1H, SCH),  
         [0041]    [0041] 13 C NMR (100 MHz, CDCl 3 ) δ 13.78 (NCHCH 3 ) 19.81 (CH(CH 3 ) 2 ), 20.78 (CH(CH 3 ) 2 ), 23.26 (—CH 2 —), 30.25 (CH(CH 3 ) 2 ), 30.72 (SCOCH 3 ), 50.64 (NCH 2 —), 54.84 (NCH), 58.89 (SCHCH 3 ), 195.56 (SCOCH 3 )  
         [0042]    Element analysis C 12 H 23 NOS theoretical: C, 62.83; H, 10.11; N, 6.11 experimental: C, 62.56; H, 10.25; N, 5.97  
         [0043]    High-resolution MS (70 eV) m/e theoretical: 299.1500 experimental: 299.1508  
         [0044]    [α]25D=+41.7 (c=0.99, CDCl 3 )  
         [0045]    Step (c): Preparing (2R,3S)-4-Methyl-3-(1-pyrrolidinyl)pentane-2-thiol (6b4c)  
                         
 
         [0046]    and (3R,4S)-2-Methyl-4-(1-pyrrolidinyl)pentane-3-thiol (2f4c)  
                         
 
         [0047]    To a three-necked flask, LAH (LiAlH 4 , 0.076 g, 2.0 mmol) and ether (10 mL) are added under nitrogen system. Next, compound (6b4b) (0.229 g, 1.0 mmol) or compound (2f4b) (0.229 g, 1.0 mmol) dissolved in 10 mL ether is slowly added into the flask within 30 min at 0° C. After reaction for 1 hour, 15% NaOH is added to the flask until a white solid is present complete. The solid is filtered and repeatedly washed with a solvent. The filtrate is then concentrated to obtain a coarse product. Column chromatography (Silica gel 40 g, eluent is n-Hexane:NEt 3 =100:1) is used to purify the coarse product and two orange liquids, compound (6b4c) (0.15 g) and compound (2f4c) (0.15 g), are obtained. The yields of compound (6b4c) and compound (2f4b) are 80% and 80%, respectively. The other analysis for compound (6b4c) includes:  
         [0048]    [0048] 1 H NMR (400 MHz, CDCl 3 ) δ 0.88 (d, J=6.8 Hz, 3H, CH(CH 3 ) 2 ), 0.93 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 1.35 (d, J=6.8 Hz, 3H, CHSHCH 3 ), 1.65-1.73 (m, 4H, —(CH 2 ) 2 —), 1.98-2.10 (m, 1H, CH(CH 3 ) 2 ), 2.55 (dd, J 1 =3.6 Hz, J 2 =7.2 Hz, 1H, NCH), 2.70-2.75 (m, 2H, NCH 2 —), 2.76-2.82 (m, 2H, NCH 2 —), 3.03-3.20 (m, 1H, CHOH)  
         [0049]    [0049] 13 C NMR (100 MHz, CDCl 3 ) δ 20.75 (CH(CH 3 ) 2 ), 21.24 (CHSHCH 3 ), 22.26 (CH(CH 3 ) 2 ), 24.49 (—CH 2 —) 29.17 (CH(CH 3 ) 2 ), 38.44 (NCH), 51.18 (NCH 2 —), 70.87 (SCH)  
         [0050]    Element analysis C 10 H 21 NS theoretical: C, 64.11; H, 11.30; N, 7.48 experimental: C, 64.35; H, 11.12; N, 7.65  
         [0051]    High-resolution MS (70 eV) m/e theoretical: 187.1395 experimental: 187.1366  
         [0052]    [α]25D=+17.4° (c=0.83, CDCl 3 )  
         [0053]    The other analysis for compound (2f4c) includes:  
         [0054]    [0054] 1 H NMR (400 MHz, CDCl 3 )  
         [0055]    δ 0.92 (d, J=6.8 Hz, 3H, CH(CH 3 ) 2 ), 1.01 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 1.04 (d, J=6.4 Hz, 3H, NCHCH 3 ), 1.69-1.75 (m, 4H, —(CH 2 ) 2 —), 1.69-1.75 (m, 1H, CH(CH 3 ) 2 ), 2.35-2.41 (m, 1H, NCH), 2.43-2.49 (m, 2H, NCH 2 —), 2.52-2.58 (m, 2H, NCH 2 —), 2.84 (dd, J 1 =4.0 Hz, J 2 =9.6 Hz, 1H, SHCH)  
         [0056]    [0056] 13 C NMR (100 MHz, CDCl 3 ) δ 12.08 (NCHCH 3 ), 20.47 (CH(CH 3 ) 2 ), 21.71 (CH(CH 3 ) 2 ), 23.27 (—CH 2 —) 31.24 (CH(CH 3 ) 2 ), 50.95 (NCH 2 —), 52.17 (NCH), 60.54 (SCH)  
         [0057]    Element analysis C 10 H 21 NS theoretical: C, 64.11; H, 11.30; N, 7.48 experimental: C, 63.98; H, 11.25; N, 7.45  
         [0058]    High-resolution MS (70 eV) m/e theoretical: 187.1395 experimental: 187.1386  
         [0059]    [α]25D=+23.7° (c=1.51,CDCl 3 )  
       EXAMPLES 3 and 4  
     Preparation of (3S,4R)-2-Methyl-3-(1-pyrrolidinyl) octane-4-thiol (6c4c) and (3R,4S)-2-Methyl-4-(1-pyrrolidinyl) octane-3-thiol (3f4c)  
       [0060]    Step (a): Preparing (3S,4R)-2-Methyl-3-(1-pyrrolidinyl)octan-4-ol (6c4a)  
                         
 
         [0061]    Repeat Step (a) of EXAMPLE 1, but (2R,3S)-3-amino-4-methyl pentan-2-ol is replaced with (3S,4R)-3-amino-2-methyloctan-4-ol. The analysis for compound  
         [0062]    (6c4a) includes:  
         [0063]    [0063] 1 H NMR(400 MHz, CDCl 3 ) δ 0.77-0.92 (m, 3H, (CH 2 ) 3 CH 3 ), 0.77-0.92 (m, 6H, CH(CH 3 ) 2 ), 1.06-1.62 (m, 6H, (CH 2 ) 3 CH 3 ), 1.62-1.81 (m, 4H, —(CH 2 ) 2 —), 1.89-2.05 (m, 1H, CH(CH 3 ) 2 ), 2.47 (dd, J 1 =4.8 Hz, J 2 =9.6 Hz, 1H, NCH), 2.74-2.86 (m, 4H, NCH 2 —), 3.45-3.52 (m, 1H, CHOH),  
         [0064]    [0064] 13 CNMR(100 MHz, CDCl 3 ) δ 13.99 (CH 2 CH 2 CH 2 CH 3 ), 20.20 (CH(CH 3 ) 2 ), 21.81 (CH(CH 3 ) 2 ), 22.66 (CH 2 CH 2 CH 2 CH 3 ), 24.23 (—CH 2 —), 27.48 (CH(CH 3 ) 2 ), 29.23 (CH 2 CH 2 CH 2 CH 3 ), 32.21 (CH 2 CH 2 CH 2 CH 3 ), 50.85 (NCH 2 —), 69.11 (NCH), 70.58 (CHOH)  
         [0065]    Element analysis C 13 H 27 NO theoretical: C, 73.18; H, 12.76; N, 6.56 experimental: C, 73.20; H, 12.63; N, 6.51  
         [0066]    High-resolution MS (70 eV) m/e theoretical: 213.2093 experimental: 214.2165  
         [0067]    [α]25D=+53.3° (c=1.03, CDCl 3 )  
         [0068]    Step (b): Preparing (3S,4R)-2-Methyl-3-(1-pyrrolidinyl)-4-thioacetyloctane (6c4b)  
                         
 
         [0069]    and (3R,4S)-2-Methyl-4-(1-pyrrolidinyl)-3-thioacetyloctane (3f4b)  
                         
 
         [0070]    Repeat Step (b) of EXAMPLE 1, but replace compound (6b4a) with compounds (6c4a) or (3f4a). Analysis for product (6c4b) includes:  
         [0071]    [0071] 1 H NMR (400 Mz CDCl 3 ) δ 0.85 (t, J=7.2 Hz, 3H, (CH 2 ) 3 CH 3 ), 0.86 (d, J=5.6 Hz, 3H, CH(CH 3 ) 2 ), 0.95 (d, J=5.6 Hz, 3H, CH(CH 3 ) 2 ), 1.20-1.50 (m, 6H, (CH 2 ) 3 CH 3 ), 1.64-1.72 (m, 4H, —(CH 2 ) 2 —), 1.85-2.12 (m, 1H, CH(CH 3 ) 2 ), 2.28 (s, 3H, SCOCH 3 ), 2.43 (dd, J 1 =2.8 Hz, J 2 =8.0 Hz, 1H, NCH), 2.58-2.66 (m, 2H, NCH 2 —), 2.68-2.77 (m, 2H, NCH 2 —), 3.80-3.88 (m, 1H, SCH),  
         [0072]    [0072] 13 C NMR (100 MHz, CDCl 3 ) δ 14.00 (CH 2 CH 2 CH 2 CH 3 ), 20.50 (CH(CH 3 ) 2 ), 21.19 (CH(CH 3 ) 2 ), 22.56 (CH 2 CH 2 CH 2 CH 3 ), 23.99 (—CH 2 —), 29.54 (CH(CH 3 ) 2 ), 29.58 (CH 2 CH 2 CH 2 CH 3 ), 30.53 (SCOCH 3 ), 32.16 (CH 2 CH 2 CH 2 CH 3 ), 47.53 (NCH), 50.79 (NCH 2 —), 70.19 (SCH), 196.26 (SCOCH 3 )  
         [0073]    Element analysis C 15 H 29 NOS theoretical: C, 66.37; H, 10.77; N, 5.16 experimental: C, 66.14; H, 10.85; N, 5.22  
         [0074]    High-resolution MS (70 eV) m/e theoretical: 271.1970 experimental: 271.1971  
         [0075]    [α]25D=+39.6° (c=1.03, CDCl 3 )  
         [0076]    Analysis for product (3f4b) includes:  
         [0077]    [0077] 1 HNMR(400 MHz CDCl 3 ) δ 0.82-0.90 (m, 3H, (CH 2 ) 3 CH 3 ), 0.82-0.90 (m, 3H, CH(CH 3 ) 2 ), 0.93 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 1.20-1.60 (m, 6H, (CH 2 ) 3 CH 3 ), 1.65-1.73 (m, 4H, —(CH 2 ) 2 —), 1.91-2.05 (m, 1H, CH(CH 3 ) 2 ), 2.31 (s, 3H, SCOCH 3 ), 2.50-2.63 (m, 4H, NCH 2 —), 2.50-2.63 (m, 1H, NCH), 3.63 (t, J=6.0 Hz, 1H, SCH),  
         [0078]    [0078] 13 C NMR (100 MHz, CDCl 3 ) δ 13.91 (CH 2 CH 2 CH 2 CH 3 ), 19.07 (CH(CH 3 ) 2 ), 20.83 (CH(CH 3 ) 2 ), 22.98 (CH 2 CH 2 CH 2  CH 3 ), 23.56 (—CH 2 —), 30.26 (CH(CH 3 ) 2 ), 30.49 (CH 2 CH 2 CH 2 CH 3 ), 30.70 (SCOCH 3 ), 30.79 (CH 2 CH 2 CH 2 CH 3 ), 49.33 (NCH 2 —), 53.70 (NCH), 61.89 (SCH), 195.68 (SCOCH 3 )  
         [0079]    Element analysis C 15 H 29 NOS theoretical: C, 66.37; H, 10.77; N, 5.16 experimental: C, 66.23; H, 10.71; N, 5.02  
         [0080]    High-resolution MS (70 eV) m/e theoretical: 271.1970 experimental: 271.1991  
         [0081]    [α]25D=+48.2° (c=1.24, CDCl 3 )  
         [0082]    Step (c): Preparing (3S,4R)-2-Methyl-3-(1-pyrrolidinyl)octane-4-thiol (6c4c)  
                         
 
         [0083]    and (3R,4S)-2-Methyl-4-(1-pyrrolidinyl) octane-3-thiol (3f4c)  
                         
 
         [0084]    Repeat Step (c) of EXAMPLE 1, but replace compound (6b4b) with compounds (6c4b) or (3f4b). Analysis for product (6c4c) includes:  
         [0085]    [0085] 1 H NMR (400 MHz, CDCl 3 ) δ 0.84-1.00 (m, 6H, CH(CH 3 ) 2 ), 0.84-1.00 (m, 3H, (CH 2 ) 3 CH 3 ), 1.16-1.35 (m, 4H, CH 2 (CH 2 ) 2 CH 3 ), 1.48-1.78 (m, 2H, CH 2 (CH 2 ) 2 CH 3 ), 1.48-1.78 (m, 4H, —(CH 2 ) 2 —), 2.00-2.13 (m, 1H, CH(CH 3 ) 2 ), 2.43 (dd, J 1 =3.6 Hz, J 2 =8.4 Hz, 1H, NCH), 2.71-2.93 (m, 4H, NCH 2 —), 2.71-2.963 (m, 1H, SHCH),  
         [0086]    [0086] 13 C NMR (100 MHz, CDCl 3 ) δ 14.07 (CH 2 CH 2 CH 2 CH 3 ), 20.88 (CH(CH 3 ) 2 ), 21.39 (CH(CH 3 ) 2 ), 22.49 (CH 2 CH 2 CH 2 CH 3 ), 24.39 (—CH 2 —), 28.90 (CH(CH 3 ) 2 ), 30.54 (CH 2 CH 2 CH 2 CH 3 ), 34.56 (CH 2 CH 2 CH 2 CH 3 ), 44.95 (NCH), 51.01 (NCH 2 —), 70.85 (CHSH)  
         [0087]    Element analysis C 13 H 27 NS theoretical: C, 68.06; H, 11.86; N, 6.11 experimental: C, 68.21; H, 11.55; N, 6.35  
         [0088]    High-resolution MS (70 eV) m/e theoretical: 229.1864 experimental: 229.1857  
         [0089]    [α]25D=+54.3° (c=10.01, CDCl 3 )  
         [0090]    Analysis for product (3f4c) includes:  
         [0091]    [0091] 1 H NMR (400 MHz, CDCl 3 ) δ 0.86-1.00 (m, 3H, (CH 2 ) 3 CH 3 ), 0.86-1.00 (m, 6H, CH(CH 3 ) 2 ), 1.23-1.50 (m, 4H, CH 2 (CH 2 ) 2 CH 3 ), 1.52-1.73 (m, 2H, CH 2 (CH 2 ) 2 CH 3 ), 1.52-1.73 (m, 4H, —(CH 2 ) 2 —), 1.75-1.92 (m, 1H, CH(CH 3 ) 2 ), 2.33 (dd, J 1 =4.4 Hz, J 2 =8.0 Hz, 1H, NCH), 2.47-2.62 (m, 4H, NCH 2 —), 2.85 (dd, J 1 =4.4 Hz, J 2 =8.0 Hz, 1H, SHCH),  
         [0092]    [0092] 13 C NMR (100 MHz, CDCl 3 ) δ 13.92 (CH 2 CH 2 CH 2 CH 3 ), 20.13 (CH(CH 3 ) 2 ), 21.23 (CH(CH 3 ) 2 ), 23.21 (CH 2 CH 2 CH 2 CH 3 ), 23.43 (—CH 2 —), 29.30 (CH 2 CH 2 CH 2 CH 3 ), 30.65 (CH(CH 3 ) 2 ), 31.42 (CH 2 CH 2 CH 2 CH 3 ), 50.24 (NCH 2 —), 51.99 (NCH), 64.56 (CHSH)  
         [0093]    Element analysis C 13 H 27 NS theoretical: C, 68.06; H, 11.86; N, 6.11 experimental: C, 68.21; H, 11.56; N, 6.01  
         [0094]    High-resolution MS (70 eV) m/e theoretical: 229.1864 experimental: 229.1857  
         [0095]    [α]25D=+38.8° (c=0.99, CDCl 3 )  
       EXAMPLE 5  
     Preparation of (3R,4S)-2,5-Dimethyl-4-(1-pyrrolidinyl)hexane-3-thiol (6f4c)  
       [0096]    Step (a): Preparing (3R,4S)-2,5-Dimethyl-4-(1-pyrrolidinyl)hexan-3-ol (6f4a)  
                         
 
         [0097]    Repeat Step (a) of EXAMPLE 1, but replace (2R,3S)-3-amino-4-methylpentan-2-ol with (3R,4S)-4-amino-2,5-dimethylhexan-3-ol. Analysis for compound (6f4a) includes:  
         [0098]    [0098] 1 H NMR (400 MHz, CDCl 3 ) δ 0.83 (d, J=6.8 Hz, 3H, NCHCH(CH 3 ) 2 ), 0.97 (d, J=6.8 Hz, 3H, NCHCH(CH 3 ) 2 ), 1.02 (d, J=1.2 Hz, 3H, CHOHCH(CH 3 ) 2 ), 1.04 (d, J=1.2 Hz, 3H, CHOHCH(CH 3 ) 2 ), 1.63-1.73 (m, 4H, —(CH 2 ) 2 —), 1.74-1.83 (m, 1H, NCHCH(CH 3 ) 2 ), 2.05-2.12 (m, 1H, CHOHCH(CH 3 ) 2 ), 2.21 (dd, J 1 =3.2 Hz, J 2 =4.0 Hz, 1H, NCH), 2.55-2.63 (m, 2H, NCH 2 —), 2.65-2.72 (m, 2H, NCH 2 —), 3.41 (dd, J 1 =4.4 Hz, J 2 =9.2 Hz, 1H, CHOH)  
         [0099]    [0099] 13 C NMR (100 MHz, CDCl 3 ) δ 19.20 (NCHCH(CH 3 ) 2 ), 19.30 (NCHCH(CH 3 ) 2 ), 19.62 (CHOHCH(CH 3 ) 2 ), 22.68 (CHOHCH(CH 3 ) 2 ), 23.40 (—CH 2 —) 26.99 (NCHCH(CH 3 ) 2 ), 30.59 (CHOHCH(CH 3 ) 2 ), 51.59 (NCH 2 —), 68.34 (NCH), 77.60 (CHOH)  
         [0100]    Element analysis C 12 H 25 NO theoretical: C, 72.31; H, 12.64; N, 7.03 experimental: C, 72.18; H, 12.73; N, 6.89  
         [0101]    High-resolution MS (70 eV) m/e theoretical: 199.1936 experimental: 200.2011  
         [0102]    [α]25D=+45.7° (c=1.21, CDCl 3 )  
         [0103]    Step (b): Preparing (3R,4S)-2,5-Dimethyl-4-(1-pyrrolidinyl)-3-thioacetylhexane (6f4b)  
                         
 
         [0104]    Repeat Step (b) of EXAMPLE 1, but replace compound (6b4a) with compound (6f4a). Analysis for product (6f4b) includes:  
         [0105]    [0105] 1 H NMR (400 MHz, CDCl 3 ) δ 0.88 (d, J=6.8 Hz, 3H, NCHCH(CH 3 ) 2 ), 0.90-0.98 (m, 3H, NCHCH(CH 3 ) 2 ), 0.90-0.98 (m, 6H, SCHCH(CH 3 ) 2 ), 1.66-1.71 (m, 4H, —(CH 2 ) 2 —), 1.88-2.00 (m, 1H, NCHCH(CH 3 ) 2 ), 2.01-2.12 (m, 1H, SCHCH(CH 3 ) 2 ), 2.34 (s, 3H, SCOCH 3 ), 2.62-2.70 (m, 2H, NCH 2 —), 2.71-2.77 (m, 2H, NCH 2 —), 2.62-2.77 (m, 1H, NCH), 3.79 (dd, J 1 =5.2 Hz, J 2 =6.4 Hz, 1H, SCH)  
         [0106]    [0106] 13 C NMR (100 MHz, CDCl 3 ) δ 18.62 (NCHCH(CH 3 ) 2 ), 19.99 (NCHCH(CH 3 ) 2 ), 21.10 (SCHCH(CH 3 ) 2 ), 21.59 (SCHCH(CH 3 ) 2 ), 24.01 (—CH 2 —) 30.44 (NCHCH(CH 3 ) 2 ), 30.54 (SCHCH(CH 3 ) 2 ), 30.70 (SCOCH 3 ), 49.24 (NCH 2 —), 50.80 (NCH), 64.73 (SCH), 195.37 (SCOCH 3 )  
         [0107]    Element analysis C 14 H 27 NOS theoretical: C, 65.32; H, 10.57; N, 5.44 experimental: C, 65.20; H, 10.81; N, 5.14  
         [0108]    High-resolution MS (70 eV) m/e theoretical: 257.1813 experimental: 257.1859  
         [0109]    [α]25D=+53.9° (c=1.23, CDCl 3 )  
         [0110]    Step (c): Preparing (3R,4S)-2,5-Dimethyl-4-(1-pyrrolidinyl)hexane-3-thiol (6f4c)  
                         
 
         [0111]    Repeat Step (c) of EXAMPLE 1, but replace compound (6b4b) with compound (6f4b). Analysis for product (6f4c) includes:  
         [0112]    [0112] 1 H NMR (400 MHz, CDCl 3 ) δ 0.89 (d, J=6.4 Hz, 3H, NCHCH(CH 3 ) 2 ), 0.92-1.06 (m, 3H, NCHCH(CH 3 ) 2 ), 0.92-1.06 (m, 6H, SHCHCH(CH 3 ) 2 ), 1.62-1.72 (m, 4H, —(CH 2 ) 2 —), 1.89-1.95 (m, 1H, NCHCH(CH 3 ) 2 ), 2.13-2.25 (m, 1H, SHCHCH(CH 3 ) 2 ), 2.52 (dd, J 1 =4.4 Hz, J 2 =8.0 Hz, 1H, NCH), 2.64-2.73 (m, 4H, NCH 2 —), 2.92 (dd, J 1 =4.4 Hz, J 2 =7.6 Hz, 1H, CHSH)  
         [0113]    [0113] 13 C NMR (100 MHz, CDCl 3 ) δ 17.63 (NCHCH(CH 3 ) 2 ), 19.56 (NCHCH(CH 3 ) 2 ), 21.57 (CHSHCH(CH 3 ) 2 ), 21.79 (CHSHCH(CH 3 ) 2 ), 24.14 (—CH 2 —) 29.40 (NCHCH(CH 3 ) 2 ), 29.69 (CHSHCH(CH 3 ) 2 ), 48.77 (NCH), 50.03 (NCH 2 —), 66.19 (CHSH)  
         [0114]    Element analysis C 12 H 25 NS theoretical: C, 66.91; H, 11.70; N, 6.50 experimental: C, 66.38; H, 10.91; N, 6.28  
         [0115]    High-resolution MS (70 eV) m/e theoretical: 215.1708 experimental: 215.1712  
         [0116]    [α]25D=+13.7° (c=0.99, CDCl 3 )  
       EXAMPLE 6  
     Preparation of (1R,2S)-3-Methyl-1-phenyl-2-(1-pyrrolidinyl) Butane-1-thiol (6g4c)  
       [0117]    Step (a): Preparing (1R,2S)-3-Methyl-1-phenyl-2-(1-pyrrolidinyl)butan-1-ol (6g4a)  
                         
 
         [0118]    Repeat Step (a) of EXAMPLE 1, but replace (2R,3S)-3-amino-4-methylpentan-2-ol with (1R,2S)-2-amino-3-methyl-1-phenylbutan-1-ol, and replace Na 2 CO 3  (1.16 g, 11.0 mmol) with K 2 CO 3  (1.52 g, 11.0 mmol). Column chromatography (Silica gel, eluent is n-Hexane:EtOAc=10:1) is used to purify the coarse product and a slightly-yellow liquid (1.00 g) is obtained. The yield is 86% and the other analysis includes:  
         [0119]    [0119] 1 H NMR (400 MHz, CDCl 3 ) δ 0.80 (d, J=6.8 Hz, 3H, CH(CH 3 ) 2 ), 0.96 (d, J=6.8 Hz, 3H, CH(CH 3 ) 2 ), 1.62-1.70 (m, 4H, —(CH 2 ) 2 —), 1.72-1.82 (m, 1H, CH(CH 3 ) 2 ), 2.54 (dd, J 1 =4.4 Hz, J 2 =8.0 Hz, 1H, NCH), 2.57-2.64 (m, 2H, NCH 2 —), 2.68-2.74 (m, 2H, NCH 2 —), 4.92 (d, J=4.0 Hz, 1H, CHOH), 7.14-7.34 (m, 5H, ArH)  
         [0120]    [0120] 13 C NMR (100 MHz, CDCl 3 ) δ 20.28 (CH(CH 3 ) 2 ), 21.81 (CH(CH 3 ) 2 ), 23.78 (—CH 2 —), 27.88 (CH(CH 3 ) 2 ), 51.47 (NCH 2 —), 72.29 (NCH), 72.51 (CHOH), 126.08, 126.62, 127.79, 142.88 (Ph)  
         [0121]    Element analysis C 15 H 23 NO theoretical: C, 77.21; H, 9.93; N, 6.00 experimental: C, 77.11; H, 9.73; N, 6.23  
         [0122]    High-resolution MS (70 eV) m/e theoretical: 233.1780 experimental: 234.1865  
         [0123]    [α]25D=−41.3° (c=1.38, CDCl 3 )  
         [0124]    Step (b): Preparing (1R,2S)-3-Methyl-1-phenyl-2-(1-pyrrolidinyl)-1-thioacetyl butane (6g4b)  
                         
 
         [0125]    Repeat Step (b) of EXAMPLE 1, but replace compound (6b4a) with compound (6g4a). Column chromatography (Silica gel, eluent is n-Hexane:NEt 3 =100:1) is used to purify the coarse product and a slightly-yellow liquid (1.09g) is obtained. The yield is 75% and the other analysis includes:  
         [0126]    [0126] 1 H NMR (400 MHz, CDCl 3 ) δ 0.90 (d, J=6.8 Hz, 3H, CH(CH 3 ) 2 ), 0.99 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 1.45-1.55 (m, 4H, —(CH 2 ) 2 —), 1.92-2.04 (m, 1H, CH(CH 3 ) 2 ), 2.26 (s, 3H, SCOCH 3 ), 2.60-2.69 (m, 4H, NCH 2 —), 2.97 (t, J=6.4 Hz, 1H, NCH), 4.99 (d, J=6.4 Hz, 1H, SCH), 7.14-7.41 (m, 5H, ArH)  
         [0127]    [0127] 13 C NMR (100 MHz, CDCl 3 ) δ 19.82 (CH(CH 3 ) 2 ), 21.62 (CH(CH 3 ) 2 ), 24.31 (—CH 2 —), 30.57 (CH(CH 3 ) 2 ), 30.59 (SCOCH 3 ), 49.69 (NCH), 50.42 (NCH 2 —), 69.33 (SCH), 126.73, 127.86, 128.70, 141.80 (Ph), 194.60 (SCOCH 3 )  
         [0128]    Element analysis C 17 H 25 NOS theoretical: C, 70.06; H, 8.65; N, 4.81 experimental: C, 69.68; H, 8.80; N, 4.63  
         [0129]    High-resolution MS (70 eV) m/e theoretical: 291.1657 experimental: 291.1661  
         [0130]    [α]25D=−240.8° (c=1.02, CDCl 3 )  
         [0131]    Step (c): Preparing (1 R,2S)-3-Methyl-1-phenyl-2-(1-pyrrolidinyl)butane-1-thiol (6g4c)  
                         
 
         [0132]    Repeat Step (c) of EXAMPLE 1, but replace compound (6b4b) with compound (6g4b). A slightly-yellow liquid (0.401g) is obtained through pumping concentration. The yield is 85% and other analysis includes:  
         [0133]    [0133] 1 H NMR (400 MHz, CDCl 3 ) δ 0.95 (d, J=7.2 Hz, 3H, CH(CH 3 ) 2 ), 0.99 (d, J=6.4 Hz, 3H, CH(CH 3 ) 2 ), 1.37-1.48 (m, 4H, —(CH 2 ) 2 —), 2.06-2.15 (m, 1H, CH(CH 3 ) 2 ), 2.54-2.70 (m, 4H, NCH 2 —), 3.00 (dd, J 1 =5.2 Hz, J 2 =7.6 Hz, 1H, NCH), 4.30 (d, J=7.6 Hz, 1H, SHCH), 7.12-7.40 (m, 5H, ArH)  
         [0134]    [0134] 13 C NMR(100 MHz, CDCl 3 ) δ 18.95 (CH(CH 3 ) 2 ), 21.67 (CH(CH 3 ) 2 ), 24.46 (—CH 2 —), 30.42 (CH(CH 3 ) 2 ), 50.60 (NCH 2 —), 70.03 (NCH), 77.20 (CHSH), 126.73, 127.9, 128.1, 144.57 (Ph)  
         [0135]    Element analysis C 15 H 23 NS theoretical: C, 72.23; H, 9.29; N, 5.62 experimental: C, 72.01; H, 9.88; N, 5.32  
         [0136]    High-resolution MS (70 eV) m/e theoretical: 249.1551 experimental: 249.1554  
         [0137]    [α]25D=−489.0° (c=1.01, CDCl 3 )  
       EXAMPLE 7  
     Preparation of (1R,2S)-1,2-Diphenyl-2-piperidin-1-yl-ethanethiol (6g5c) Step (a): Preparing (6g5a)  
       [0138]    [0138]                           
         [0139]    Repeat Step (a) of EXAMPLE 6, but replace 1,4-dibromobutane with 1,5-dibromopentane. Column chromatography (Silica gel, eluent is n-Hexane:EtOAc=10:1) is used to purify the coarse product and a slightly-yellow liquid (1.00 g) is obtained. The yield is 86% and the other analysis includes:  
         [0140]    [0140] 1 H NMR (400 MHz, CDCl 3 ) δ 0.80 (d, J=6.8 Hz, 3H, CH(C H   3 ) 2 ), 0.96 (d, J=6.8 Hz, 3H, CH(C H   3 ) 2 ), 1.62-1.70 (m, 4H, —(C H   2 ) 2 —), 1.72-1.82 (m, 1H, C H (CH 3 ) 2 ), 2.54 (dd, J 1 =4.4 Hz, J 2 =8.0 Hz, 1H, NCH), 2.57-2.64 (m, 214, NCH 2 —), 2.68-2.74 (m, 2H, NCH 2 —), 4.92 (d, J=4.0 Hz, 1H, C H OH), 7.14-7.34 (m, 5H, ArH)  
         [0141]    [0141] 13 C NMR (100 MHz, CDCl 3 ) δ 20.28 (CH( C H 3 ) 2 ), 21.81 (CH( C H 3 ) 2 ), 23.78 (—CH 2 —), 27.88 ( C H(CH 3 ) 2 ), 51.47 (NCH 2 —), 72.29 (N C H), 72.51 ( C HOH), 126.08, 126.62, 127.79, 142.88 (Ph)  
         [0142]    Element analysis C 18 H 21 NO theoretical: C, 77.21; H, 9.93; N, 6.00 experimental: C, 77.11; H, 9.73; N, 6.91  
         [0143]    High-resolution MS (70 eV) m/e theoretical:233.1780 experimental: 234.1865  
         [0144]    [α] 25   D =−41.3 (c=1.38, CHCl 3 )  
         [0145]    Step (b): Preparing (1R,2S)-Thioavcetic acidS-(3-methyl-1-phenyl-2-pyrrolidin-1-yl-butyl)ester (6g5b)  
                         
 
         [0146]    Repeat Step (b) of EXAMPLE 6, but replace compound (6g4a) with compound (6g5a). Column chromatography (Silica gel, eluent is n-Hexane:NEt 3 =100:1) is used to purify the coarse product and a slightly-yellow liquid (1.09 g) is obtained. The yield is 75% and the other analysis includes:  
         [0147]    [0147] 1 H NMR(40 MHz, CDCl 3 ) δ 0.90 (d, J=6.8 Hz, 3H, CH(C H   3 ) 2 ), 0.99 (d, J=6.4 Hz, 3H, CH(C H   3 ) 2 ), 1.45-1.55 (m, 4H, —(C H   2 ) 2 —), 1.92-2.04 (m, 1H, C H (CH 3 ) 2 ), 2.26 (s, 3H, SCOC H   3 ), 2.60-2.69 (m, 4H, NCH 2 —), 2.97 (t, J=6.4 Hz, 1H, NCH), 4.99 (d, J=6.4 Hz, 1H, SCH), 7.14-7.41 (m, 5H, ArH)  
         [0148]    [0148] 13 C NMR (100 MHz, CDCl 3 ) δ 19.82 (CH( C H 3 ) 2 ), 21.62 (CH( C H 3 ) 2 ), 24.31 (—CH 2 —), 30.57 ( C H(CH 3 ) 2 ), 30.59 (SCO C H 3 ), 49.69 (NCH), 50.42 (NCH 2 —), 69.33 ( C HSCOCH 3 ), 126.73, 127.86, 128.70, 141.80 (Ph), 194.60 (S C OCH 3 )  
         [0149]    Element analysis C 21 H 25 NOS theoretical: C, 70.06; H, 8.65; N, 4.81; S 11.00 experimental: C, 69.68; H, 8.80; N, 4.63; S11.13  
         [0150]    High-resolution MS (70 eV) m/e theoretical: 291.1657 experimental: 291.1661  
         [0151]    [α] 25   D =−240.8 (c=1, CHCl 3 )  
         [0152]    Step (c): Preparing (1R,2S)-3-Methyl-1-phenyl-2-pyrrolidin-1-yl-butane-1-thiol (6g5c)  
                         
 
         [0153]    Repeat Step (c) of EXAMPLE 6, but replace compound (6g4b) with compound (6g5b). A slightly-yellow liquid (0.401 g) is obtained. The yield is 85%, and the other analysis includes:  
         [0154]    [0154] 1 H NMR (400 MHz, CDCl 3 ) δ 0.95 (d, J=7.2 Hz, 3H, CH(C H   3 ) 2 ), 0.99 (d, J=6.4 Hz, 3H, CH(C H   3 ) 2 ), 1.37-1.48 (m, 4H, —(C H   2 ) 2 —), 2.06-2.15 (m, 1H, C H (CH 3 ) 2 ), 2.54-2.70 (m, 4H, NCH 2 —), 3.00 (dd, J 1 =5.2 Hz, J 2 =7.6 Hz, 1H, NCH), 4.30 (d, J=7.6 Hz, 1H, SHC H ), 7.12-7.40 (m, 5H, ArH)  
         [0155]    [0155] 13 C NMR (100 MHz, CDCl 3 ) δ 18.95 (CH( C H 3 ) 2 ), 21.67 (CH( C H 3 ) 2 ), 24.46 (—CH 2 —), 30.42 ( C H(CH 3 ) 2 ), 50.60 (NCH 2 —), 70.03 (N C H), 77.20 ( C HSH), 126.73, 127.9, 128.1, 144.57 (Ph),  
         [0156]    Element analysis C 24 H 33 NOS theoretical: C, 72.23; H, 9.29; N, 5.62 experimental: C,72.01; H, 9.88; N, 5.32  
         [0157]    High-resolution MS (70 eV) m/e theoretical: 249.1551 experimental: 249.1554  
         [0158]    [α] 25   D =−489.0 (c=1, CHCl 3 )  
       EXAMPLE 8  
     Preparation of (1R,2S)-1,2-Diphenyl-2-piperidin-1-yl-ethanethiol (7g4c) Step (a): Preparing (1R,2S)-1,2-Diphenyl-2-pyrrolidine-1-yl-ethanol (6g5a)  
       [0159]    [0159]                           
         [0160]    Repeat Step (a) of EXAMPLE 6, but replace (1R,2S)-2-amino-1-phenyl-3-methyl-butanol with (1R,2S)-2-amino-1,2-diphenyl-ethanol. Column chromatography (Silica gel, eluent is n-Hexane:EtOAc=5:1) is used to purify the coarse product and a white solid (1.24 g) is obtained. The yield is 93% and the other analysis includes:  
         [0161]    [0161] 1 H NMR(400 MHz, CDCl 3 ) δ 1.82-1.85 (m, 4H, N(CH 2 C H   2 ) 2 ), 2.59-2.62 (m, 2H, NCH 2 ), 2.74-2.76 (m, 2H, NCH 2 ), 3.30 (d, J=3.2 Hz, 1H, NCH), 5.24 (d, J=3.0 Hz, 1H, C H OH), 6.97-7.25 (m, 10H, ArH)  
         [0162]    [0162] 13 C NMR(100 MHz, CDCl 3 ) δ 23.47 (N(CH 2   C H 2 ) 2 ), 52.94 (N(CH 2 ) 2 ), 73.99 (NCH), 77.31 (CHOH), 126.08, 126.70, 127.02, 127.19, 127.42, 129.25, 137.47, 140.69 (2Ph)  
         [0163]    Element analysis C 18 H 21 NO theoretical: C,80.86; H,7.91; N,5.24 experimental: C,81.06; H,7.65; N,5.11  
         [0164]    High-resolution MS (70 eV) m/e theoretical: 267.3649 experimental: 267.3688  
         [0165]    [α] 25   D =−87.5 (c=1, CHCl 3 )  
         [0166]    melt point: 113.65±0.45° C.  
         [0167]    Step (b): Preparing (1R,2S)-1,2-Diphenyl-2-pyrrolidine-1-yl-1-thioacetyl-ethane (7g4b)  
                         
 
         [0168]    Repeat Step (c) of EXAMPLE 6, but replace compound (6g4b) with compound (7g4a). Column chromatography (Silica gel, eluent is n-Hexane:NEt 3 =100:1) is used to purify the coarse product and a yellow liquid (1.33 g) is obtained. The yield is 82% and the other analysis includes:  
         [0169]    [0169] 1 H NMR (400 MHz, CDCl 3 ) δ 1.74-1.78 (m, 4H, N(CH 2 C H   2 ) 2 ), 2.28 (s, 3H, COCH 3 ), 2.50-2.57 (m, 4H, N(CH 2 ) 2 ), 3.48 (d, J=4.8 Hz, 1H, NCH), 5.25 (d, J=5.2 Hz, 1H, SCH), 6.88-7.26 (m, 10H, ArH)° 
         [0170]    [0170] 13 C NMR (100 MHz, CDCl 3 ) δ 23.33 (N(CH 2   C H 2 ) 2 ), 30.83 (COCH 3 ), 52.62 (N(CH 2 ) 2 ), 52.85 (NCH), 74.99 (SCH), 126.88, 127.48, 127.59, 128.88, 129.00, 138.64, 140.33 (2Ph), 196.58 (S C OCH 3 )  
         [0171]    Element analysis C 20 H 23 NOS theoretical: C, 73.81; H, 7.12; N, 4.30 experimental: C, 73.55; H, 7.26; N, 4.38  
         [0172]    High-resolution MS (70 eV) m/e theoretical: 325.4737 experimental: 325.4245  
         [0173]    [α] 25   D =−32.5 (c=1, CHCl 3 )  
         [0174]    Step (c): Preparing (1R,2S)-1,2-Diphenyl-2-pyrrolidine-1-yl-ethane-1-thiol (7g4c)  
                         
 
         [0175]    Repeat Step (c) of EXAMPLE 6, but replace compound (6g4b) with compound (7g4b). A slightly-yellow liquid (0.43 g) is obtained. The yield is 76%, and the other analysis includes:  
         [0176]    [0176] 1 H NMR (400 MHz, CDCl 3 ) δ 1.72-1.79 (m, 4H N(CH 2 C H   2 ) 2 ), 2.29(s, 1H, SH), 2.45-2.51 (m, 2H, NCH 2 ), 2.55-2.61 (m, 2H, NCH 2 ), 3.46 (d, J=5.6 Hz, 1H, NCH), 4.70 (d, J=5.2 Hz, 1H, CHSH), 6.96-7.36 (m, 10 H, ArH)  
         [0177]    [0177] 13 C NMR (100 MHz, CDCl 3 ) δ 23.47 (N(CH 2   C H 2 ) 2 ), 48.60 (NCH), 52.30(N(CH 2 ) 2 ), 75.70 (CHSH), 127.05, 127.09, 127.35, 127.72, 128.63, 129.79, 137.40, 140.85 (2Ph)  
         [0178]    Element analysis C 18 H 21 NS theoretical: C,76.28; H,7.47; N,4.94 experimental: C,76.06; H,7.28; N,5.23  
         [0179]    High-resolution MS (70 eV) m/e theoretical: 283.4369 experimental: 283.4348  
         [0180]    [α] 25   D =−162.0 (c=1, CHCl 3 )  
       EXAMPLE 9  
     Preparation of (1R,2S)-1,2-Diphenyl-2-piperidin-1-yl-ethanethiol (7g5c)  
       [0181]    Step (a): Preparing (1R,2S)-1,2-Diphenyl-2-piperidin-1-yl-ethanol (7g5a)  
                         
 
         [0182]    Repeat Step (a) of EXAMPLE 6, but replace (1R,2S)-2-amino-1-phenyl-3-methyl-butanol with (1R,2S)-2-amino-1,2-diphenyl-ethanol, and replace 1,4-dibromobutane with 1,5-dibromopentane. Column chromatography (Silica gel 50g, eluent is n-Hexane:EtOAc=5:1) is used to purify the coarse product and a white solid (1.28 g) is obtained. The yield is 91% and the other analysis includes:  
         [0183]    [0183] 1 H NMR (400 MHz, CDCl 3 ) δ 1.45-1.49 (m, 2H, ((CH 2 ) 2 CH 2 (CH 2 ) 2 )), 1.55-1.62 (m, 4H, N(CH 2 CH 2 ) 2 ), 2.47-2.55 (m, 2H, NCH 2 ), 2.62 (br, 2H, NCH 2 ), 3.38 (d, J=4.0 Hz, 1H, NCH), 5.38 (d, J=4.0 Hz, 1H, CHOH), 6.98-7.26 (m, 10H, ArH)  
         [0184]    [0184] 13 C NMR (100 MHz, CDCl 3 ) δ 24.60 ((CH 2 ) 2 CH 2 (CH 2 ) 2 ), 26.28 (N(CH 2 CH 2 ) 2 ), 52.51 (N(CH 2 ) 2 ), 71.55 (NCH), 76.42 (CHOH), 126.14, 126.58, 127.01, 127.42, 129.43, 136.64, 141.38 (2Ph)  
         [0185]    IR ν max  (cm −1 ) 3131 (OH)  
         [0186]    Element analysis C 19 H 23 NO theoretical: C,81.10; H,8.24; N,4.98; 0,5.68 experimental: C,81.65; H,8.41; N,4.72; 0,5.22  
         [0187]    High-resolution MS (70 eV) m/e theoretical: 281.1780 experimental: 281.1770  
         [0188]    [α] 25   D =−74.2 (c=1.2, CHCl 3 )  
         [0189]    melting point: 93-95° C.  
         [0190]    Step (b): Preparing (1R,2S)-1,2-Diphenyl-2-piperidin-1-yl-1-thioacetyl-ethane (7g5b)  
                         
 
         [0191]    Repeat Step (b) of Example 6, but the compound (6g4a) is replaced with the compound (7g5a). Column chromatography (Silica gel 70g, eluent is n-Hexane:NEt 3 =160:1) is used to purify the coarse product and an orange solid (1.46g) is obtained. The yield is 86% and the other analysis includes:  
         [0192]    [0192] 1 H NMR (400 MHz, CDCl 3 ) δ 1.20 (br, 2H, ((CH 2 ) 2 CH 2 (CH 2 ) 2 )), 1.26 (br, 2H, NCH 2 CH 2 ), 1.31 (br, 2H, NCH 2 CH 2 ), 2.14 (s, 3H, COCH 3 ), 2.14 (br, 2H, NCH 2 ), 2.41 (br, 2H, NCH 2 ), 3.82 (d, J=10.4 Hz, 1H, NCH), 5.31 (d, J=10.4 Hz, 1H, SCH), 7.10-7.31 (m, 10H, ArH)  
         [0193]    [0193] 13 C NMR (100 MHz, CDCl 3 ) δ 24.42 ((CH 2 ) 2 CH 2 (CH 2 ) 2 ), 26.04 (N(CH 2 CH 2 ) 2 ), 30.49 (COCH 3 ), 48.78 (NCH) 50.71 (N(CH 2 ) 2 ), 73.28 (SCH), 126.67, 127.32, 127.59, 127.81, 128.25, 128.72, 136.03, 141.72 (2Ph)  
         [0194]    Element analysis C 21 H 25 NOS theoretical: C,74.29; H,7.42; N,4.13; 0,4.71; S9.45 experimental: C,74.19; H,7.10; N,4.49; 0,4.52; S9.70  
         [0195]    high-resolution MS (70 eV) m/e theoretical: 339.5005 experimental: 339.5436  
         [0196]    Step (c): Preparing (1R,2S)-1,2-Diphenyl-2-piperidin-1-yl-ethanethiol (7g5c)  
                         
 
         [0197]    Repeat Step (c) of EXAMPLE 1, but compound (6g4b) is replaced with compound (7g5b). A transparent liquid (0.505 g) is obtained. The yield is 85% and the other analysis includes:  
         [0198]    [0198] 1 H NMR (400 MHz, CDCl 3 ) δ 1.16-1.29 (m, 6H, (C H   2 (C H   2 CH 2 ) 2 N), 2.01 (SH), 2.18(br, 2H, CH 2 (CH 2 C H   2 ) 2 N), 2.34 (br, 2H, CH 2 (CH 2 C H   2 ) 2 N), 3.78 (d, J=4.8 Hz, 1H, NCH), 4.68 (d, J=4 Hz, 1H, SCH), 7.14-7.30 (m, 10H, ArH)  
         [0199]    [0199] 13 C NMR (100 MHz, CDCl 3 ) δ 24.42 ((CH 2 ) 2   C H 2 (CH 2 ) 2 ), 26.12 (N(CH 2   C H 2 ) 2 ), 44.75(NCH) 50.86 (N(CH 2 ) 2 ), 76.36 (SCH), 126.84, 127.32, 127.61, 127.89, 128.03, 129.22, 135.75, 142.03 (2Ph)  
         [0200]    Element analysis C 18 H 21 NS theoretical: C, 76.72; H, 7.79; N, 4.71; S, 10.78 experimental: C, 76.85; H, 7.83; N, 4.75; S, 10.82  
         [0201]    High-resolution MS (70 eV) m/e theoretical: 297.1551 experimental: 298.0035  
         [0202]    [α] 25   D =−122.0 (c=1, CHCl 3 )  
       EXAMPLE 10  
     Preparation of (1R,2S)-1,2-Diphenyl-2-morpholin-4-yl-ethane-1-thiol (7g6c)  
       [0203]    Step (a): Preparing (1R,2S)-1,2-Diphenyl-2-morpholin-4-yl-ethanol (7g6a)  
                         
 
         [0204]    Repeat Step (a) of EXAMPLE 6, but replace (1R,2S)-2-amino-1-phenyl-3-methyl-butanol with (1R,2S)-2-amino-1,2-diphenylethanol, and replace 1,4-dibromobutane with (BrC 2 H 4 ) 2 O. Column chromatography (Silica gel 50 g, eluent is n-Hexane:EtOAc=4:1) is used to purify the coarse product and a white solid (1.34 g) is obtained. The yield is 95% and the other analysis includes:  
         [0205]    [0205] 1 H NMR (400 MHz, CDCl 3 ) δ 2.51-2.56 (m, 2H, N(CH 2 ) 2 ), 2.66 (br, 2H, N(CH 2 ) 2 ), 3.30 (s, 1H, OH), 3.36 (d, J=4.0 Hz, 1H, NCH), 3.70-3.76 (m, 4H, O(CH 2 ) 2 ), 5.33 (d, J=4.0 Hz, 1H, CHOH), 6.94-7.26 (m, 10H, ArH)  
         [0206]    [0206] 13 C NMR (100 MHz, CDCl 3 ) δ 51.96 (N(CH 2 ) 2 ), 67.11 (O(CH 2 ) 2 ), 71.18 (NCH), 76.44 (CHOH), 126.11, 126.87, 127.40, 127.56, 127.60, 129.54, 135.56, 140.81 (2Ph)  
         [0207]    IR ν max  (cm −1 ) 3127 (OH)  
         [0208]    Element analysis C 18 H 21 NO 2  theoretical: C,76.33; H,7.46; N,4.93; O, 11.28 experimental: C,76.38; H,7.36; N,4.90; O,11.36  
         [0209]    High-resolution MS (70 eV) m/e theoretical: 283.1573 experimental: 283.1570  
         [0210]    [α] 25   D =−140.7 (c=1.4, CHCl 3 )  
         [0211]    melting point: 123-125° C.  
         [0212]    Step (b): Preparing (1R,2S)-1,2-Diphenyl-2-morpholin-4-yl-1-thioacetyl-ethane (7g6b)  
                         
 
         [0213]    Repeat Step (b) of EXAMPLE 6, but replace compound (6g4a) with compound (7g6a). Column chromatography (Silica gel 70 g, eluent is n-Hexane:NEt 3 =100:1) is used to purify the coarse product and an orange solid (1.57 g) is obtained. The yield is 92% and the other analysis includes:  
         [0214]    [0214] 1 H NMR (400 MHz, CDCl 3 ) δ 2.20 (s, 3H, COCH 3 ), 2.31-2.35 (m, 2H, N(CH 2 ) 2 ), 2.46 (m, 2H, N(CH 2 ) 2 ), 3.51(m, 4H, O(CH 2 ) 2 ), 3.72 (d, J=8.8 Hz, 1H, NCH), 5.28 (d, J=8.4 Hz, 1H, SCH), 7.05-7.27 (m, 10H, ArH)  
         [0215]    [0215] 13 C NMR (100 MHz, CDCl 3 ) δ 30.58(COCH 3 ), 48.88(NCH), 50.49 (N(CH 2 ) 2 ), 66.95(O(CH 2 ) 2 ), 73.63(SCH), 126.93, 127.72, 127.78, 127.86, 128.43, 128.94, 135.88, 140.87 (2Ph)  
         [0216]    Element analysis C 20 H 23 NO 2 S theoretical: C,70.35; H,6.79; N,4.10; O,9.37; S9.39 experimental: C,70.85; H,6.14; N,4.69; O,6.17; S9.15  
         [0217]    High-resolution MS (70 eV) m/e theoretical: 341.4727 experimental: 341.4794  
         [0218]    Step (c): Preparing (1R,2S)-1,2-Diphenyl-2-morpholin-4-yl-ethane-1-thiol (7g6c)  
                         
 
         [0219]    Repeat Step (c) of EXAMPLE 6, but replace compound (6g4b) with compound (7g6b). Column chromatography (Silica gel 40 g, eluent is n-Hexane:NEt 3 =300:1) is used to purify the coarse product and a white solid (0.31 g) is obtained. The yield is 53% and the other analysis includes:  
         [0220]    [0220] 1 H NMR (400 MHz, CDCl 3 ) δ 1.96(s, 1H, SH), 2.39-2.46 (m, 4H, N(CH 2 ) 2 ), 3.48-3.56 (m, 4H, O(CH 2 ) 2 ), 3.71 (d, J=8.4 Hz, 1H, NCH), 4.70 (d, J=8.4 Hz, 1H, CHSH), 7.12-7.30 (m, 10H, ArH)  
         [0221]    [0221] 13 C NMR (100 MHz, CDCl 3 ) δ 44.75 (NCH), 50.44 (N(CH 2 ) 2 ), 66.95 (O(CH 2 ) 2 ), 75.87 (CHSH), 127.10, 127.67, 127.94, 128.14, 129.44, 135.10, 141.24 (2Ph)  
         [0222]    Element analysis C 18 H 21 NOS theoretical: C,72.20; H,7.07; N,4.68; O,5.34; S10.71 experimental: C,72.33; H,7.12; N,4.47; O,5.33; S10.75  
         [0223]    High-resolution MS (70 eV) m/e theoretical: 299.4359 experimental: 299.4358  
         [0224]    [Application Mode 1] 
         [0225]    To show effect of the aminothiol of the present invention in addition reactions of organic zinc and aldehyde, diethylzinc (ZnEt 2 ) and benzaldehyde are provided to perform the following reaction:  
                         
 
         [0226]    Table 2 lists chiral ligands and conditions applied in the addition reaction. In the application, the chiral ligand obtained in the above EXAMPLEs is added into a dried flask at an equivalence concentration (N lig ). The flask is then sealed and vacuumed to remove moisture and then filled with nitrogen. Diethylzinc (ZnEt 2 ) dissolved in toluene or hexane is added in the flask at an equivalence concentration (NZE) and a proper temperature. Next, under a specific temperature (T rxn ), benzaldehyde (0.11 mL, 1.0 mmol) is added into the flask and stirred for a period (t rxn ). To terminate the reaction, 1N aqueous HCl (1 mL) is added into the above solution. The solution is then extracted with acetyl acetate (20 mL), wherein the organic layer is collected and dehydrated with anhydrous MgSO 4 , and then the mixture is filtered. The filtrate is concentrated by reducing pressure through an air pump to obtain crude product. The crude product is purified by column chromatography (Silica gel, eluent is n-Hexane: EtOAc=10: 1).  
         [0227]    HPLC (high-pressure liquid chromatography) with Daicel Chiralcel OD Column is provided for determining enantiomeric excess (e.e.) of the product, wherein the eluent is n-hexane:i-propanol=98.0:2.0, flow rate is 1.5 ml/min. In the above addition reaction of ZnEt 2  and various aldehyde, peaks of products are present at different time, as indicated in Table 3. The enantiomeric excess (e.e.) can be determined according to the following equation:  
         e   .   e   .                (   %   )       =              S   -   R            S   +   R       ×   100                 %                           
 
         [0228]    wherein (S+R) in denominator is the product obtained without adding chiral ligands of the present invention;  
         [0229]    S or R in numerator is the product obtained by adding chiral ligands of the present invention.  
                                                                                     TABLE 2                               N lig         N ZE         t rxn     T rxn     e.e.       EXAMPLE   Ligand   (meq)   S/C   (meq)   Solvent   (h)   (° C.)   (%)                                1   6b4c   0.05   20   1.2   Toluene   12   −20   96.5 R       2   2f4c   0.05   20   1.2   Toluene   12   −20   95.7 R       3   6c4c   0.05   20   1.2   Toluene   12   −20   94.2 R       4   3f4c   0.05   20   1.2   Toluene   12   −20   93.2 R       5   6f4c   0.05   20   1.2   Toluene   12   −20   99.6 R               0.05   20   1.2   Toluene   6   rt   98.5 R               0.05   20   1.2   Toluene   12   0   99.3 R               0.05   20   1.2   Toluene   12   −20   99.6 R               0.05   20   1.2   Hexane   12   −20   99.2 R               0.05   20   1.2   T/THF   12   −20   92.1 R               0.05   20   1.2   T/CH2Cl2   12   −20   99.5 R               0.05   20   1.2   T/C6H6   12   −20   99.6 R               0.05   20   2   Toluene   12   −20   99.6 R               0.05   20   3   Toluene   12   −20   99.5 R               0.05   20   4   Toluene   12   −20   99.5 R               0.05   20   5   Toluene   12   −20   99.5 R               0.05   20   1.2   Toluene   12   −40   99.7 R               0.05   20   1.2   Toluene   24   −78   90.2 R           6f4c   0.5   2   1.2   Toluene   12   −20   99.6 R               0.2   5   1.2   Toluene   12   −20   99.6 R               0.05   20   1.2   Toluene   12   −20   99.6 R               0.001   1000   1.2   Toluene   12   −20   99.2 R               0.0005   2000   1.2   Toluene   12   −20   98.5 R               0.0001   10000   1.2   Toluene   12   −20   96.5 R       6       0.05   20   1.2   Toluene   6   rt   98.3 R           6g4c   0.05   20   1.2   Toluene   12   0   99.3 R               0.05   20   1.2   Toluene   12   −20   99.5 R               0.05   20   1.2   Toluene   12   −40   99.6 R               0.05   20   1.2   Toluene   24   −78   88.2 R       7   6g5c   0.05   20   1.2   Toluene   12   rt   99.0 R               0.05   20   1.2   Toluene   12   0   99.0 R               0.05   20   1.2   Toluene   12   −20   99.6 R               0.01   100   1.2   Toluene   12   −20   99.0 R               0.001   1000   1.2   Toluene   12   −20   98.1 R               0.05   20   1.2   Toluene   12   −40   99.6 R               0.05   20   1.2   Toluene   12   −78   93.7 R       8   7g4c   0.1   10   5   Toluene   12   −20   99.3 R               0.1   10   4   Toluene   12   −20   99.5 R               0.1   10   3.7   Toluene   12   −20   99.5 R               0.1   10   3   Toluene   12   −20   99.4 R               0.1   10   2   Toluene   12   −20   99.3 R               0.1   10   1.2   Toluene   12   −20   99.3 R               0.05   20   1.2   Toluene   6   rt   99.1 R               0.05   20   1.2   Toluene   9   0   99.2 R               0.05   20   1.2   Toluene   12   −20   99.3 R               0.05   20   1.2   Toluene   12   −40   99.5 R               0.05   20   1.2   Toluene   24   −78   94.2 R               0.0002   5000   3.7   Toluene   12   −20   99.0 R               0.0005   2000   3.7   Toluene   12   −20   99.1 R               0.001   1000   3.7   Toluene   12   −20   99.2 R       8   7g4c   0.003   333   3.7   Toluene   12   −20   99.3 R               0.006   167   3.7   Toluene   12   −20   99.3 R               0.01   100   3.7   Toluene   12   −20   99.3 R               0.02   50   3.7   Toluene   12   −20   99.4 R               0.05   20   3.7   Toluene   12   −20   99.4 R               0.1   10   3.7   Toluene   12   −20   99.5 R               0.2   5   3.7   Toluene   12   −20   99.5 R               0.4   3   3.7   Toluene   12   −20   98.8 R       9   7g5c   0.1   10   3.7   Toluene   12   −20   99.7 R               0.05   20   2   Toluene   12   0   99.7 R       10   7g6c   0.1   10   3.7   Toluene   12   −20   99.5 R                  
 
         [0230]    In Table 2, S/C is an equivalence ratio of benzaldehyde (substrate, 1.0 mmol) to the chiral ligand. As shown in Table 2, the chiral ligands of the present invention exhibit superior enantioselectivity in the asymmetric of benzaldehyde and diethyl zinc, even as S/C are very high. For example, when compounds (6f4c), (6g5c) and (7g4c) obtained from EXAMPLEs 5, 7 and 8 are applied at S/C as high as 1,000, enantiomeric excess are more than 98%. Therefore, aminothiol compounds in the present invention are indeed very economic for applying the above asymmetric reactions to industries.  
         [0231]    Table 3 list more aminothiol compounds with various ligands and application results thereof in varied reaction conditions. These aminothiol compounds can be produced through similar procedures of above EXAMPLEs by supplying proper reactants having respective ligands. Therefore, detailed description is omitted in the specification.  
         [0232]    In Table 3, Compound (5g3c) has the following formula.  
                         
 
         [0233]    The related analysis of Compound (5g3c) include:  
         [0234]    [0234] 1 H NMR (400 MHz, CDCl 3 ) δ 3.04-3.22(m, 2H, PhCH 2 ), 3.503.60 (m, 1H, CNH), 3.60 (s, 4H, PhCH 2 N), 4.37 (t, J=4.0 Hz, 1H, PhCHS), 6.81-7.41 (m, 20H, ArH)  
         [0235]    [0235] 13 C NMR (100 MHz, CDCl 3 ) δ 24.68, 26.53, 46.06, 51.41, 72.86, 125.83, 126.81, 127.94, 128.10, 128.14, 129.31, 140.85, 143.663.  
         [0236]    Element analysis C 29 H 29 NS  
                                                                             TABLE 3                           N lig         N ZE         t rxn     T rxn     e.e.       Ligand   (meq)   S/C   (meq)   Solvent   (h)   (° C.)   (%)                                2g5c   0.05   20   2   Hexane   12   0   100.0 R           0.05   20   1.2   Toluene   12   rt   91.0 R           0.05   20   1.2   Toluene   12   0   97.9 R       4g5c   0.0005   2000   1.2   Toluene   12   −20   97.7 R           0.0001   10000   1.2   Toluene   12   −20   98.1 R           0.005   200   1.2   Toluene   12   −20   98.1 R           0.001   1000   1.2   Toluene   12   −20   98.1 R           0.05   20   1.2   Toluene   12   −20   98.9 R           0.1   10   1.2   Toluene   12   −20   98.9 R           0.2   5   1.2   Toluene   12   −20   98.8 R           0.05   20   1.2   Toluene   12   −40   99.3 R       5g2c   0.05   20   1.2   Toluene   12   rt   96.9 R       5g3c   0.05   20   1.2   Toluene   12   0   93.5 R       5g4c   0.05   20   1.2   Toluene   12   0   98.9 R       5g5c   0.05   20   5   Toluene   12   0   99.1 R           0.05   20   4   Toluene   12   0   99.4 R           0.05   20   3   Toluene   12   0   99.4 R           0.05   20   2   Toluene   12   0   99.3 R           0.05   20   1.2   Toluene   12   0   99.3 R           0.05   20   1.1   Toluene   12   0   99.3 R           0.05   20   1.2   Hexane   12   0   99.1 R           0.05   20   1.2   T/CH2Cl2   12   0   99.1 R           0.05   20   1.2   T/THF   12   0   72.0 R           0.0001   10000   1.2   Toluene   12   0   98.1 R           0.0002   5000   1.2   Toluene   12   0   98.9 R       5g5c   0.0005   2000   1.2   Toluene   12   0   99.0 R           0.001   1000   1.2   Toluene   12   0   99.1 R           0.002   500   1.2   Toluene   12   0   99.1 R           0.005   200   1.2   Toluene   12   0   99.2 R           0.01   100   1.2   Toluene   12   0   99.3 R           0.02   50   1.2   Toluene   12   0   99.3 R           0.05   20   1.2   Toluene   12   0   99.3 R           0.1   10   1.2   Toluene   12   0   99.4 R           0.2   5   1.2   Toluene   12   0   99.4 R           0.5   2   1.2   Toluene   12   0   99.4 R           1   1   1.2   Toluene   12   0   99.0 R           0.05   20   1.2   Toluene   3   rt   98.1 R           0.05   20   1.2   Toluene   12   0   99.3 R           0.05   20   1.2   Toluene   18   −20   99.4 R           0.05   20   1.2   Toluene   24   −40   99.4 R           0.05   20   1.2   Toluene   48   −78   87.9 R           0.05   20   1.2   Toluene   0.5   rt   97.8 R           0.05   20   1.2   Toluene   1   rt   98.1 R           0.05   20   1.2   Toluene   1.5   rt   98.1 R       5g5c   0.05   20   1.2   Toluene   3   rt   98.1 R           0.05   20   1.2   Toluene   6   rt   98.1 R       5g6c   0.05   20   1.2   Toluene   12   0   98.2 R       6g1c   0.05   20   1.2   Toluene   12   −20   97.7 R       6g2c   0.05   20   1.2   Toluene   12   −20   99.4 R       6g6c   0.05   20   1.2   Toluene   12   0   99.1 R           0.05   20   1.2   Toluene   12   −20   99.4 R                  
 
         [0237]    As shown in Table 3, the aminothiol compounds of the present invention indeed perform excellent catalysts to obtain high enantiomeric excess in the asymmetric addition reaction of benzaldehyde and diethyl zinc.  
         [0238]    Similarly, the aminothiol compounds of the present invention can be provided as chiral ligands to react with other organic metals, for example, Cu, to form organometal complexes. These complexes can also react with carbonyl such as aldehyde, to produce alcohol in the asymmetric addition reactions.  
         [0239]    [Application Mode 2] 
         [0240]    The aminothiol compounds of the present invention also show superior effect in catalizing an addition reaction as follows:  
                         
 
         [0241]    In this reaction, butyl acetylene (or hexyl acetylene), diethylzinc (ZnEt 2 ) and aldehyde are reacted to produce allyl alcohol in existence of chiral ligands of the present invention. Table 4 lists conditions and results of the reaction catalized with different ligands including Compound (6g5c) obtained in Example 7, Compound (7g5c) obtained in Example 9, Compound (7g6c) obtained in Example 10 and Compound (6f5c).  
                                                   TABLE 4                                                   Conver-                           Mole %   T rxn     N ZE     t rxn     sion   Yield   e.e       Ligand   Ar   R′   of ligand   (° C.)   (eq)   (h)   (%)   (%)   (%)                       Ph   C 4 H 9     5(T)   −10   2   15   100   89   91.3(R)           Ph   C 4 H 9     5(T)   −20   2   15   100   94   99.0(R)           Ph   C 4 H 9     5(T)   −20   2   15   100   94   98.3(R)       6f5c   Ph   C 4 H 9     1(T)   −30   2   15   100   90   94.3(R)           Ph   C 4 H 9     2(T)   −30   2   15   100   92   94.5(R)           Ph   C 4 H 9     5(T)   −30   2   15   100   94   98.2(R)           Ph   C 6 H 13     2(T)   −30   2   15   100   65   99.0(R)           4—OMe—Ph   C 6 H 13     2(T)   −30   2   15   100   90   98.1(R)           2—Cl—Ph   C 6 H 13     2(T)   −30   2   15   100   86   92.6(R)           Ph   C 6 H 13      2(H)       −30   2   15   100   80   99.0(R)           Ph   C 4 H 9     5(T)   −30   2   15   100   94   98.2(R)           2—Cl—Ph   C 4 H 9     5(T)   −30   2   15   100   —   98.1(R)           Ph   C 6 H 13     5(T)   −30   2   15   100   —   99.4(R)           Ph   C 4 H 9     5(T)   −40   2   15   100   94   98.3(R)           Ph   C 4 H 9     15(T)    −30   2   15   100   —   99.5(R)       6g5c   Ph   C 4 H 9     5(T)   −30   2   15   100   92   96.1(R)           Ph   C 6 H 13     2(T)   −30   2   15   100   92   98.6(R)       7g5c   Ph   C 4 H 9     5(T)   −30   2   15   100   91   95.6(S)           Ph   C 4 H 9     5(T)   −30   2   15   100   93   97.0(R)           Ph   C 6 H 13     2(T)   −30   2   15   100   93   98.4(R)           Ph   C 6 H 13     5(T)   −30   2   15   100   68   98.3(R)       7g6c   Ph   C 4 H 9     5(T)   −30   2   15   100   95   97.3(R)                  
 
         [0242]    In Application Mode 2, ZnEt 2  and aldehyde are respectively added by syringe pump over 20 minutes. T and H in the column (mole % of ligand) are the solvents toluene and hexane. Detailed procedures may be referred to Wolfgang Oppolzer et al. (J. Org. Chem. 2001, 66, 4766-4770) and Brase S. et al. (Org. Lett. 2001, 3, 4119). Enantiometric access is determined with HPLC (Chiralcel OD-H column, flow rate 0.7 ml/min, 3% isopropanol).  
         [0243]    It should be noticed that the above embodiments are only used for explaining the present invention, but not limiting the scope.